PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.544
https://www.valueinhealthjournal.com/article/S1098-3015(11)00683-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1109
First Page :
A97
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00683-8&doi=10.1016/j.jval.2011.02.544